Original Research
Published on 05 Feb 2026
BRAF and MEK inhibition beyond dabrafenib–trametinib in advanced thyroid cancer: a real-world case series
in Thyroid Endocrinology
- 525 views
Original Research
Published on 05 Feb 2026
in Thyroid Endocrinology
Original Research
Accepted on 04 Feb 2026
in Bone Research
Original Research
Accepted on 04 Feb 2026
in Clinical Diabetes
Original Research
Accepted on 04 Feb 2026
in Clinical Diabetes
Original Research
Published on 04 Feb 2026
in Reproduction
Original Research
Published on 04 Feb 2026
in Cellular Endocrinology
Review
Published on 04 Feb 2026
in Obesity
Review
Published on 04 Feb 2026
in Clinical Diabetes
Original Research
Published on 04 Feb 2026
in Bone Research
Original Research
Published on 04 Feb 2026
in Thyroid Endocrinology
Original Research
Accepted on 03 Feb 2026
in Cancer Endocrinology
Systematic Review
Accepted on 03 Feb 2026
in Cancer Endocrinology
Original Research
Accepted on 03 Feb 2026
in Pediatric Endocrinology
Review
Accepted on 03 Feb 2026
in Bone Research
Original Research
Accepted on 03 Feb 2026
in Bone Research
Systematic Review
Accepted on 03 Feb 2026
in Clinical Diabetes
Clinical Trial
Accepted on 03 Feb 2026
in Reproduction
Systematic Review
Accepted on 03 Feb 2026
in Clinical Diabetes
Original Research
Accepted on 03 Feb 2026
in Reproduction
Original Research
Accepted on 03 Feb 2026
in Clinical Diabetes
Original Research
Accepted on 03 Feb 2026
in Clinical Diabetes
Review
Accepted on 03 Feb 2026
in Bone Research
Case Report
Accepted on 03 Feb 2026
in Pediatric Endocrinology
Systematic Review
Published on 03 Feb 2026
in Renal Endocrinology